CLOSE X
GO

Nippon India Pharma Fund(G)

very highequitypharma & health care
420.38 -3.48(-0.82%) NAV as on 18 Apr 2024
-0.6 % 1 M
49.16 % 1 Y
16.08 % 3 Y

Growth Chart of the Scheme vis a vis benchmark (SIP value 10,000)

  • 1M
  • 3M
  • 6M
  • 1Y
  • 3Y
  • 5Y
  • 10Y
  • max

FUND OBJECTIVE

The primary investment objective of the Scheme is to generate consistent returns by investing in equity / equity related or fixed income securities of Pharma and other associated companies

SCHEME DETAILS

expense_ration-icon Expenses Ratio :

1.83

As on 31 Mar, 2024
age-icon Age :

19 yrs 10 m

Since 05 06 ,2004
exit_load Exit Load :

1%

aum AUM :

7,125.28 Crs

lock_in Lock-in :

1% on or before 1M, Nil after 1M

investing_style Investing Style :

Large Growth

Portfolio_book_value Portfolio Price To Book Value :

7.75

Min_Investment Min. Investment :

SIP 100 & Lumpsum 5000

Scheme_benchmark Scheme Benchmark :

S&P BSE HEALTH CARE - TRI

Fund_manager Fund Manager :

Sailesh Raj Bhan

LATEST ASSET & PORTFOLIO ALLOCATION

as on Mar 31 ,2024
Others 2.84 %
Equity 97.16 %

TOP HOLDINGS

Sun Pharmaceutical Industries...14.91 %
Lupin Ltd.8.40 %
Cipla Ltd.6.51 %
Apollo Hospitals Enterprise Ltd.5.79 %
Dr. Reddy's Laboratories Ltd.4.75 %
See All Holding

ALLOCATION BY MARKET CAP

ALLOCATION BY SECTOR

Pharmaceuticals & Drugs80.92
Hospital & Healthcare Services15.13
Business Support1.11
See All Sectors

5-YEARS HISTORY

Financial Year2019-20202020-20212021-20222022-20232023-2024
NAV in Rs (as on 31-Mar-2024)143.39250.18290.14270.59428.87
Net Assets(Rs Crores) (as on 31-Mar-2024) 2189.84 4260.99 4931.89 4304.46 7125.28
Scheme Returns(%)(Absolute)-5.8377.3614.83-6.8558.24
B'mark Returns(%)(Absolute)NANANANANA
Category Rank14/7532/7543/7565/7617/90

RISKOMETER Level of Risk in the Scheme

Investors understand that their principal will be at very high risk

PERFORMANCE COMPARISON WITH SIMILAR SCHEMES

Nippon India Pharma Fund(G)Very HighEquity420.38-3.48(-0.82%)NAV As on 18 Apr, 202405-Jun-2004Inception Date7,125.28AUM In Cr.49.16%1Y16.08%3Y22.34%5Y20.69%Since Inception
SBI Healthcare Opp Fund-Reg(G)Very HighEquity340.22-3.11(-0.91%)NAV As on 18 Apr, 202414-Jul-1999Inception Date2,626.34AUM In Cr.53.83%1Y18.38%3Y22.98%5Y16.11%Since Inception
ICICI Pru Pharma Healthcare & Diagnostics (P.H.D) Fund-(G)Very HighEquity30.20-0.24(-0.79%)NAV As on 18 Apr, 202413-Jul-2018Inception Date3,772.32AUM In Cr.56.31%1Y17.65%3Y24.05%5Y21.11%Since Inception
DSP Healthcare Fund-Reg(G)Very HighEquity32.270.11(0.35%)NAV As on 18 Apr, 202430-Nov-2018Inception Date2,352.32AUM In Cr.50.29%1Y16.64%3Y25.35%5Y24.32%Since Inception
Tata India Pharma & Healthcare Fund-Reg(G)Very HighEquity24.75-0.21(-0.86%)NAV As on 18 Apr, 202428-Dec-2015Inception Date878.70AUM In Cr.50.37%1Y16.39%3Y21.93%5Y11.52%Since Inception
Mirae Asset Healthcare Fund-Reg(G)Very HighEquity30.55-0.27(-0.86%)NAV As on 18 Apr, 202402-Jul-2018Inception Date2,235.15AUM In Cr.45.56%1Y14.98%3Y23.23%5Y21.24%Since Inception
ATTENTION INVESTORS NSDL/CDSL KYC Advisory for investors